TOLREMO therapeutics' Series A Round

TOLREMO therapeutics raised a round of funding on September 24, 2018.

TOLREMO therapeutics is working to discover and develop targeted therapeutics that will extend the lives of patients suffering from cancer.…

Articles about TOLREMO therapeutics' Series A Round: